Other combinations and cancer applications have been widely explored in clinical trials, such as association with gemcitabine, a pyrimidine nucleotide [56,57,58], and with atezolizumab, a monoclonal antibody against the programmed cell death-ligand 1 protein (PD-L1) [59,60], with good results in terms of patient outcome. This evidence concerns the gene CD274 and cancer.